This inventor holds 2 USPTO granted patents and 5 published patent applications. Top assignee: The University of Texas System. Active years: 2023-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2025
Title: Mayela Mendt: Innovator in MSC-Derived Exosome Production
Introduction
Mayela Mendt is a prominent inventor based in Houston, TX (US), known for her groundbreaking work in the field of exosome production derived from mesenchymal stem cells (MSCs). With a total of 2 patents, her contributions are paving the way for advancements in therapeutic applications.
Latest Patents
Mendt's latest patents focus on innovative methods for the production of MSC-derived exosomes. These patents detail the processes for manufacturing clinical-grade exosomes and include techniques for loading these exosomes with therapeutic agents, such as siRNA. Furthermore, her work outlines methods for treating diseases through the administration of these clinical-grade exosomes.
Career Highlights
Mendt is affiliated with the University of Texas System, where she continues to push the boundaries of research in her field. Her dedication to innovation has established her as a key figure in the development of exosome-based therapies.
Collaborations
Some of her notable coworkers include Elizabeth J Shpall and Raghu Kalluri, who contribute to the collaborative efforts in advancing research and applications in this area.
Conclusion
Mayela Mendt's work in MSC-derived exosome production represents a significant advancement in medical science, with the potential to revolutionize treatment methodologies. Her innovative patents and collaborations highlight her commitment to improving healthcare through scientific research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile